` BOI (Boiron SA) vs DAX Index Comparison - Alpha Spread

BOI
vs
D
DAX Index

Over the past 12 months, BOI has underperformed DAX Index, delivering a return of +7% compared to the DAX Index's +16% growth.

Stocks Performance
BOI vs DAX Index

Loading
BOI
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BOI vs DAX Index

Loading
BOI
DAX Index
Difference
www.alphaspread.com

Performance By Year
BOI vs DAX Index

Loading
BOI
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Boiron SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Boiron SA
Glance View

Market Cap
442.3m EUR
Industry
Pharmaceuticals

Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

BOI Intrinsic Value
32.42 EUR
Undervaluation 22%
Intrinsic Value
Price €25.2
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett